Timm H. Jessen
Directeur Général chez SCIENAMICS GmbH
Profil
Timm H.
Jessen was the founder of 2cureX ApS (founded in 2006) and SCIENAMICS GmbH (founded in 2004), where he holds the title of Director and Chief Executive Officer respectively.
He was also the founder of Topas Therapeutics GmbH (founded in 2015) and 2cureX AB (founded in 2006), where he held the title of Chief Executive Officer and Independent Director respectively.
Dr. Jessen is also the founder of DeveloGen AG.
Dr. Jessen's former job positions include Chief Executive Officer at bionamics GmbH, Member at Hoechst AG, Chief Operating & Scientific Officer-OAL at Evotec SE (from 1997 to 2004), and Principal at Hmr.
In terms of education, Dr. Jessen obtained an undergraduate degree from the University of Kiel and a doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Timm H. Jessen
| Sociétés | Poste | Début |
|---|---|---|
SCIENAMICS GmbH
 SCIENAMICS GmbH Advertising/Marketing ServicesCommercial Services SCIENAMICS GmbH offers services for life science companies in the area of scientific marketing, business development and strategic consulting. It offers services for public Sector, academia, investors, pharma and biotech companies. The company was founded by Timm H. Jessen on July 1, 2004 and is headquartered in Schleswig, Germany. | Directeur Général | 19/06/2009 |
Anciens postes connus de Timm H. Jessen
| Sociétés | Poste | Fin |
|---|---|---|
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Fondateur | 01/08/2020 |
| EVOTEC SE | Directeur des opérations | 01/06/2004 |
| 2CUREX AB | Fondateur | - |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Fondateur | - |
DeveloGen AG
 DeveloGen AG Pharmaceuticals: MajorHealth Technology DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes. DeveloGen develops highly innovative approaches for the treatment of diabetes and obesity targeting key pathophysiological mechanisms such as insulin resistance and loss of insulin-producing beta cells. DeveloGen's product pipeline includes two programs at advanced stages of lead optimization, a small molecule inhibitor program based on a novel and proprietary target to address insulin resistance (type 2 diabetes). A growth factor targeting beta cell regeneration (type 1 and type 2 diabetes). DeveloGen is based in Goettingen, Germany. | Fondateur | 05/11/2009 |
Formation de Timm H. Jessen
| University of Kiel | Undergraduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EVOTEC SE | Health Technology |
| 2CUREX AB | Health Technology |
| Entreprise privées | 7 |
|---|---|
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
Hmr
 Hmr Miscellaneous Commercial ServicesCommercial Services Hmr is a French company that specializes in the restoration of historic monuments. The private company is based in Tossiat, France. The company offers services such as size stone masonry and hemp lime plaster. | Commercial Services |
DeveloGen AG
DeveloGen AG Pharmaceuticals: MajorHealth Technology DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes. DeveloGen develops highly innovative approaches for the treatment of diabetes and obesity targeting key pathophysiological mechanisms such as insulin resistance and loss of insulin-producing beta cells. DeveloGen's product pipeline includes two programs at advanced stages of lead optimization, a small molecule inhibitor program based on a novel and proprietary target to address insulin resistance (type 2 diabetes). A growth factor targeting beta cell regeneration (type 1 and type 2 diabetes). DeveloGen is based in Goettingen, Germany. | Health Technology |
bionamics GmbH
 bionamics GmbH Miscellaneous Commercial ServicesCommercial Services bionamics GmbH was an asset management. It used to acquire or license assets in the pre-clinical phase, redirect some as assets for new and appropriate customers or develops these into the clinics, and commercializes the projects into the pharma and biotech industry. The firm offers represent a unique project based investment opportunity. It identifies and evaluates projects from academia, biotech and pharmaceutical companies. The company was headquartered in Kiel, Germany. | Commercial Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
SCIENAMICS GmbH
SCIENAMICS GmbH Advertising/Marketing ServicesCommercial Services SCIENAMICS GmbH offers services for life science companies in the area of scientific marketing, business development and strategic consulting. It offers services for public Sector, academia, investors, pharma and biotech companies. The company was founded by Timm H. Jessen on July 1, 2004 and is headquartered in Schleswig, Germany. | Commercial Services |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Health Technology |
